05B · Claim Check
Barzolvolimab · Celldex Atopic dermatitis · NCT06727552
- Readout
- Barzolvolimab · Celldex Atopic dermatitis · NCT06727552 (opens another website in a new tab)
- What the registry or primary source says
- Phase 2. Primary: percent change in itch score (PP-NRS) at week 16. N=131; active, not recruiting; primary completion 05.06.2026.
- What the headline says
- Primary missed at both doses; program stopped
- Verdict
- Match
Bookmarks need a Mind Club sign-in. How sign-in works
Read it in Claim Check